Management of ErbB2-positive breast cancer: Insights from preclinical and clinical studies with lapatinib

QR Code

Management of ErbB2-positive breast cancer: Insights from preclinical and clinical studies with lapatinib

Bibliographic Details
Main Authors:	Vogel, C., Chan, Arlene, Gril, B., Kim, S., Kurebayashi, J., Liu, L., Lu, Y., Moon, H.
Format:	Journal Article
Published:	Oxford University Press 2010
Online Access:	http://hdl.handle.net/20.500.11937/14131

Similar Items

In silico study of the ErbB4 interactions with curcumin analogs
by: Azman, Putri Arsyadian, et al.
Published: (2015)

Comparison of tumour biomarker HER-2/neu (C-erbB-2) before and after surgery in breast cancer patients
by: Aung, Sanda, et al.
Published: (2014)

Detection of Human Papillomavirus, p53 and c-erbB-2 Protein Expression in Juvenile Laryngeal Papillomatosis: A Report of 2 Cases
by: Siti Aishah Md Ali,, et al.
Published: (2006)

Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2014)

Detection of Isocitrate Dehydrogenase (IDH-1), Epidermal Growth Factor Receptor (EGFR), P53 and C-erbB2/HER2 mutation in glial tumour
by: Azman, Nusaibah, et al.
Published: (2022)

Evaluation of the proper dosage of lapatinib and its safety in dogs
by: Tanaka, Yuiko, et al.
Published: (2020)

Neratinib in HER-2-positive breast cancer: Results to date and clinical usefulness
by: Chan, Arlene
Published: (2016)

Human CD3+ T-cells with the anti-ERBB2 chimeric antigen receptor exhibit efficient targeting and induce apoptosis in ERBB2 overexpressing breast cancer cells
by: Munisvaradass, Rusheni, et al.
Published: (2017)

Development of cordycepin formulations for preclinical and clinical studies
by: Lee, Jong Bong, et al.
Published: (2017)

Clinical and preclinical studies of fermented foods and their effects on Alzheimer’s disease
by: Kumar, Muganti Rajah, et al.
Published: (2022)

The outcome of breast cancer based on the expression of c-erbb2 , estrogen receptor and progesterone receptor: kelantan experience 2002-2004
by: Mohamed, Moharzudi
Published: (2010)

Retention of Knowledge in Preclinical Disciplines by Clinical Students in the IIUM Medical Programme
by: Hasan, Taufiq Hidayat, et al.
Published: (2013)

Retention of knowledge in preclinical disciplines by clinical students in the IIUM medical programme
by: Hidayat, Taufik, et al.
Published: (2013)

Anti-allergic properties of propolis: evidence from preclinical and clinical studies
by: Kong, Yen Liew, et al.
Published: (2022)

Nigella plants – traditional uses, bioactive phytoconstituents, preclinical and clinical studies
by: Salehi, Bahare, et al.
Published: (2021)

A comprehensive review on the anticancer potential of bacteriocin: preclinical and clinical studies
by: Goh, Kar Shin, et al.
Published: (2022)

Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen
by: Rusheni Munisvaradass,, et al.
Published: (2017)

Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen
by: Munisvaradass, Rusheni, et al.
Published: (2017)

HER2 positive metastatic breast cancer: What happens after first line failure?
by: Chan, Arlene
Published: (2016)

Immunohistochemical studies on the expression of cea, c-erbb-2 and cathepsin din tissue sections and fine needle aspirates of benign breast lesions
by: J, Hasnan, et al.
Published: (2003)

Deepening democracy in Indonesia? direct elections for local leaders (Pilkada)/ Maribeth Erb, Priyambudi Sulistiyanto
by: Moniruzzaman, Md.
Published: (2009)

Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/ HER2-negative breast cancer-the evaluating treatment with neoadjuvant abraxane (ETNA) trial a randomized phase 3 clinical trial
by: Gianni, L., et al.
Published: (2018)

Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: Preclinical and clinical evidence
by: Shanmugam, M., et al.
Published: (2014)

Expression of c-erbb-2 in upper gastrointestinal tract carcinoma and its associations with metastasis
by: Yunus, Nor Hayati
Published: (2012)

Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply
by: Chan, Arlene, et al.
Published: (2016)

Potential benefits of edible berries in the management of aerodigestive and gastrointestinal tract cancers: Preclinical and clinical evidence
by: Bishayee, A., et al.
Published: (2016)

Preclinical safety evaluation of WJMSCs and their secretome
by: Premasangery Kathivaloo,, et al.
Published: (2025)

Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
by: Chan, Arlene, et al.
Published: (2012)

Preclinical Evaluation of Andrographis Paniculata (burm.f.) Wall. Ex Ness as Herbal Medicine for Treatment of Breast and Prostate Cancers
by: Yong, Audrey Chee Hu
Published: (2011)

Preclinical evidence of Malay traditional herbal supplement for diabetes
by: Abdul Majid, Fadzilah Adibah, et al.
Published: (2016)

TILs in metastatic breast cancer—no surprises, but more questions
by: Chan, Arlene
Published: (2017)

Therapeutic potential of palm oil vitamin E-derived tocotrienols in inflammation and chronic diseases: Evidence from preclinical and clinical studies
by: Zainal, Zaida, et al.
Published: (2022)

A new insight on the effects of Schiff Base Iron (III) complexes in breast cancer cells for clinical radiotherapy
by: Talik Sisin, Noor Nabilah, et al.
Published: (2024)

Adjuvant trastuzumab in HER2-positive breast cancer.
by: Slamon, D., et al.
Published: (2011)

Capecitabine and vinorelbine in metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2009)

Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination
by: Sengupta, Pinaki Ranjan, et al.
Published: (2017)

Molecular targets modulated by fangchinoline in tumor cells and preclinical models
by: Mérarchi, M., et al.
Published: (2018)

“Speedy Biochemistry” as a new teaching method in preclinical curriculum
by: Noor Akmal Shareela Ismail,
Published: (2020)

Assessment of knowledge on forensic anatomy among preclinical medical students
by: Manah Chandra Changmai,, et al.
Published: (2016)

Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
by: Chan, Arlene
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e0e0g99gmjg56jkdrlguem60fb